• Agora
  • Eioc Mededge
MedEdge MEA MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Reading: Illumina appoints Everett Cunningham as Chief Commercial Officer
Share
Notification
  • Agora
  • Eioc Mededge
MedEdge MEA
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Have an existing account? Sign In
MedEdge MEA > Resource Hub > Personnel > Illumina appoints Everett Cunningham as Chief Commercial Officer
PersonnelNews

Illumina appoints Everett Cunningham as Chief Commercial Officer

ME Desk
ME Desk
Published: June 5, 2024
Share
2 Min Read
Illumina appoints Everett Cunningham as Chief Commercial Officer
SHARE

SAN DIEGO- June, 2024- Illumina announced the appointment of Everett Cunningham as Chief Commercial Officer (CCO), effective June 10.

Illumina, Inc., announced the appointment of Everett Cunningham as Chief Commercial Officer, effective June 10. Cunningham will be responsible for building, guiding, and managing the company’s global commercial organization. Most recently, Cunningham served as Chief Commercial Officer at Exact Sciences.

Moreover, Cunningham will be responsible for building, guiding, and managing the company’s global commercial organization. He brings extensive commercial experience across the healthcare tech, life sciences, and pharmaceutical industries. Most recently, Cunningham served as Chief Commercial Officer at Exact Sciences, where he oversaw the company’s marketing, sales, and customer service functions. Prior to Exact Sciences, he held various senior leadership roles at Quest Diagnostics, GE Healthcare, and Pfizer, where he spent 21 years as a commercial leader.

Cunningham has a demonstrated track record of success in driving operational excellence, delivering top-line results, and expanding into new markets. He effectively leads teams through transformational change to better serve customers, earning recognition as a strong leader.

Also Read: Mayo Clinic names new Department of Neurosurgery chair in Rochester

“I am thrilled to welcome Everett to the Illumina leadership team as we work to deliver on Illumina’s mission to improve human health by unlocking the power of the genome,” said Jacob Thaysen, Illumina CEO. “He brings tremendous commercial leadership experience to the role, along with a passion for solving some of the world’s most pressing healthcare challenges. I am looking forward to seeing all that he and our global commercial teams can do together, capitalizing on our leadership position in next generation sequencing, and delivering the products, services, and solutions that address customers’ most pressing needs.”

Furthermore, Cunningham will be relocating to San Diego. He succeeds Bas Verhoef, interim CCO and Head of Region, Europe, since January 2024. Verhoef will continue as Head of Region for Europe beginning June 10.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article UF Health St. Johns appoints new executives UF Health St. Johns appoints new executives
Next Article Lilly, UNICEF expand support to help millions of young people at risk of NCDs Lilly, UNICEF expand support to help millions of young people at risk of NCDs

Recent Posts

  • From Skin Types to Chronic Conditions: Dr. Jawaher Al Naqbi | AIDA 2025
  • Merck to Host Investor Event Highlighting Advances in HIV Treatment and Prevention Pipeline
  • National University Hospital (Singapore) is First to Receive International Healthcare Sustainability Certification
  • Roche Announces Retirement of Key Executives
  • WHO Supports Health Response in Flood Affected Mokwa, Niger State
  • LifeSpin
  • Health ExpoIraq
  • Agora
  • Holistic Health Middle East
  • Holistic Health Middle East MedEdge
Two Point Five Logo white
  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: Illumina appoints Everett Cunningham as Chief Commercial Officer
Share

Published by Two Point Five Media FZCO

  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: Illumina appoints Everett Cunningham as Chief Commercial Officer
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?